STOCK TITAN

Guardian Pharmacy (GRDN) director acquires 641,869 Class A shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Guardian Pharmacy Services, Inc. director and officer David K. Morris exercised a derivative position, converting 641,869 shares of Class B common stock into 641,869 shares of Class A common stock at an exercise price of $0.0000 per share.

Following the transaction on March 28, 2026, Morris directly owned 896,341 shares of Class A common stock. According to the company’s Amended and Restated Certificate of Incorporation, his Class B shares automatically convert into Class A shares on a one-for-one basis in substantially equal tranches on March 28, 2026 and September 27, 2026.

Positive

  • None.

Negative

  • None.
Insider Morris David K
Role See Remarks
Type Security Shares Price Value
Exercise Class B Common Stock 641,869 $0.00 --
Exercise Class A Common Stock 641,869 $0.00 --
Holdings After Transaction: Class B Common Stock — 641,870 shares (Direct); Class A Common Stock — 896,341 shares (Direct)
Footnotes (1)
  1. [object Object]
Derivative exercise 641,869 shares Class B common stock converted to Class A on March 28, 2026
Exercise price $0.0000 per share Conversion of Class B into Class A common stock
Class A holdings after transaction 896,341 shares Direct ownership of Class A common stock following March 28, 2026 conversion
Automatic conversion schedule Two tranches Substantially equal tranches on March 28, 2026 and September 27, 2026
Class B common stock financial
"the Reporting Person's shares of Class B common stock automatically convert"
A class B common stock is one of multiple types of a company’s ordinary shares that carries specific rights—often different voting power or dividend priority—compared with other classes. For investors it matters because those differences affect how much influence you have over company decisions, the income you might receive, and how freely the shares trade; think of it like owning a car with different keys: some keys let you start the engine and open the trunk, others only unlock the door.
Class A common stock financial
"convert into shares of the Issuer's Class A common stock, on a one-for-one basis"
Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.
Amended and Restated Certificate of Incorporation regulatory
"Pursuant to Guardian Pharmacy Services, Inc.'s Amended and Restated Certificate of Incorporation"
A company’s amended and restated certificate of incorporation is an updated version of its foundational legal charter that replaces the older document and folds in all changes into one clear copy; it spells out corporate structure, classes of stock, shareholder rights and key governance rules. Investors care because it can change who controls the company, how votes are counted, what claims shareholders have on assets or dividends, and can introduce or remove protections against takeovers—like updating a house title after a major renovation to show who owns what and under what rules.
Exercise or conversion of derivative security financial
"transaction_code_description: Exercise or conversion of derivative security"
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Morris David K

(Last)(First)(Middle)
300 GALLERIA PARKWAY SE, SUITE 800

(Street)
ATLANTA GEORGIA 30339

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Guardian Pharmacy Services, Inc. [ GRDN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
See Remarks
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
03/28/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Class A Common Stock03/28/2026M641,869A(1)896,341D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Class B Common Stock(1)03/28/2026M641,869 (1) (1)Class A Common Stock641,869(1)641,870D
Explanation of Responses:
1. Pursuant to Guardian Pharmacy Services, Inc.'s (the "Issuer") Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in substantially equal tranches on each of March 28, 2026 and September 27, 2026.
Remarks:
Executive Vice President and Chief Financial Officer
/s/ Douglas Towns, Attorney-in-Fact03/31/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did GRDN director David K. Morris report?

David K. Morris reported exercising a derivative position to convert 641,869 shares of Class B common stock into 641,869 shares of Class A common stock at an exercise price of $0.0000 per share, reflecting an automatic conversion under the company’s charter.

How many Guardian Pharmacy (GRDN) Class A shares does David K. Morris hold after this filing?

After the transaction, David K. Morris directly holds 896,341 shares of Guardian Pharmacy’s Class A common stock. This increase reflects the conversion of 641,869 Class B shares into Class A shares, as disclosed in the March 28, 2026 Form 4 filing.

What happened to David K. Morris’s Class B common stock in GRDN?

A tranche of David K. Morris’s Class B common stock automatically converted into 641,869 shares of Class A common stock on March 28, 2026, on a one-for-one basis, pursuant to Guardian Pharmacy’s Amended and Restated Certificate of Incorporation.

Was the GRDN insider transaction a market buy or sell?

The transaction was not an open-market buy or sell. It was an exercise or conversion of a derivative security, moving 641,869 shares from Class B common stock into Class A common stock at an exercise price of $0.0000 per share, with no market trade reported.

How does Guardian Pharmacy’s charter affect David K. Morris’s GRDN shares?

Guardian Pharmacy’s Amended and Restated Certificate of Incorporation provides that Morris’s Class B common stock automatically converts into Class A common stock on a one-for-one basis in substantially equal tranches on March 28, 2026 and September 27, 2026, driving the reported conversion.